SCHEMBL15977830

SCHEMBL15977830

CC1(C)c2ccccc2-c2ccc(-c3c4ccccc4c(-c4ccccc4)c4cc(-c5ccc(-c6cccnc6)cn5)ccc34)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 5/20 0.43
CYP3A4 P08684 2/20 0.36
CYP2A6 P11509 2/20 0.36
CYP11B1 P15538 3/20 0.36
CYP11B2 P19099 2/20 0.36
KIT P10721 1/20 0.35
PDPK1 O15530 1/20 0.35
MAPK10 P53779 1/20 0.34
PIM1 P11309 2/20 0.34
PIM3 Q86V86 2/20 0.34
PIM2 Q9P1W9 2/20 0.34
PIK3CA P42336 1/20 0.34
DHODH Q02127 1/20 0.34
LMNA P02545 1/20 0.33
RAF1 P04049 1/20 0.33
CYP1A2 P05177 1/20 0.33
MAPK1 P28482 1/20 0.33
HIF1A Q16665 1/20 0.33
CCNT1 O60563 1/20 0.33
CCNA2 P20248 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15977827 0.98 PDK2 (0.45) PDK2CYP3A4CYP2A6CYP11B1CYP11B2
SCHEMBL15977521 0.97 PDK2 (0.45) PDK2CYP3A4CYP2A6CYP11B1CYP11B2
SCHEMBL15977514 0.95 PDK2 (0.47) PDK2CYP3A4CYP2A6CYP11B1CYP11B2
SCHEMBL15977847 0.92 PDK2 (0.38) PDK2CYP11B1CYP11B2PDPK1MAPK10
SCHEMBL15977617 0.89 PDK2 (0.51) PDK2CYP3A4CYP11B1CYP11B2PIM1
SCHEMBL15977733 0.89 PDK2 (0.43) PDK2CYP2A6DHODHTNKS
SCHEMBL15977835 0.89 PDK2 (0.40) PDK2KITPDPK1MAPK10PIK3CA
SCHEMBL13487899 0.88 PDK2 (0.47) PDK2CYP3A4CYP11B1CYP11B2MAPK10
SCHEMBL13488129 0.88 PDK2 (0.49) PDK2CYP3A4CYP11B1CYP11B2PIM1
SCHEMBL15977926 0.87 PDK2 (0.46) PDK2CYP3A4CYP2A6CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 PDK2 924/4885CYP3A4 1266/4885CYP2A6 3184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.